9h
Interesting Engineering on MSNFDA approves first-ever rapid-acting insulin biosimilar for diabetes treatmentFirst-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Age differences are seen in the efficacy of treatments for type 2 diabetes, according to a study published online Feb. 3 in the Journal of the American Medical ...
• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...
Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...
Misuse of prescribed stimulants, tranquilizers, and pain relievers by 18- to 49-year-olds was twice that of those without ...
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
Treating older people with diabetes is challenging due to multiple medical comorbidities that might interfere with patients' ...
2d
The Healthy on MSNHow I Knew I Had Pre-Diabetes: A Patient’s Story of Reversing Diabetes Before It Kicked InIf left untreated, prediabetes can progress to Type 2 diabetes and increase the risk of serious complications, including heart disease, stroke, kidney issues and nerve damage. The good news? Early ...
Conventional markers used for diagnosing and managing diabetes have recently come to question. This blog addresses some of ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Diabetes UK reported that more than 12 million people in the UK are now living with diabetes or prediabetes. The total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results